Bank of America Corp DE Sells 105,071 Shares of Ralliant Corporation $RAL

Key Points

• Bank of America reduced its Ralliant stake by 24.1%, selling 105,071 shares in the first quarter and retaining 330,906 shares worth approximately $13.8 million.
• Ralliant insiders also sold shares under pre-arranged Rule 10b5-1 plans: CEO Tamara Newcombe sold about $928,675 worth, while SVP Karen Bick sold $436,464 worth.
• Analyst sentiment remains generally positive, with a “Moderate Buy” consensus and an average price target of $75.70; Ralliant recently beat quarterly EPS estimates and issued fiscal 2026 guidance of $2.76–$2.90 per share.

Bank of America Corp DE cut its holdings in Ralliant Corporation (NYSE:RAL - Free Report) by 24.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 330,906 shares of the company's stock after selling 105,071 shares during the quarter. Bank of America Corp DE owned 0.30% of Ralliant worth $13,762,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of RAL. Cetera Investment Advisers purchased a new stake in shares of Ralliant in the second quarter worth approximately $700,000. Russell Investments Group Ltd. purchased a new stake in Ralliant in the second quarter worth $1,465,000. EverSource Wealth Advisors LLC bought a new stake in shares of Ralliant during the second quarter worth $39,000. First Trust Advisors LP bought a new stake in shares of Ralliant during the second quarter worth $2,013,000. Finally, Federated Hermes Inc. purchased a new stake in shares of Ralliant during the second quarter valued at $326,000.

Insider Buying and Selling at Ralliant

In other news, CEO Tamara S. Newcombe sold 12,936 shares of the company's stock in a transaction on Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares of the company's stock, valued at $18,088,710.93. This represents a 4.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the sale, the senior vice president owned 31,668 shares in the company, valued at $2,280,096. The trade was a 16.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Vertical Research lowered shares of Ralliant from a "buy" rating to a "hold" rating and set a $65.00 price objective for the company. in a report on Wednesday, May 27th. Barclays lifted their price target on shares of Ralliant from $52.00 to $67.00 and gave the company an "overweight" rating in a research note on Wednesday, May 13th. Wall Street Zen upgraded Ralliant from a "buy" rating to a "strong-buy" rating in a report on Saturday. Evercore began coverage on Ralliant in a research note on Tuesday, June 9th. They issued an "outperform" rating and a $80.00 price objective on the stock. Finally, Oppenheimer raised their price objective on Ralliant from $50.00 to $65.00 and gave the stock an "outperform" rating in a report on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $75.70.

Ralliant Stock Performance

RAL opened at $63.72 on Friday. The company has a market cap of $7.05 billion, a P/E ratio of -5.87, a price-to-earnings-growth ratio of 2.37 and a beta of 1.60. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. The firm's 50-day moving average price is $68.94 and its 200-day moving average price is $55.92. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $75.41.

Ralliant (NYSE:RAL - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.63 by $0.05. The business had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant's payout ratio is presently -1.84%.

About Ralliant

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source